XML 20 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Interim Condensed Statements of Changes in Equity - USD ($)
$ in Thousands
Preferred A Shares Microbot Medical Ltd. Pre-Merger [Member]
Preferred A Shares Microbot Medical Inc. Post-Merger [Member]
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Temporary Equity [Member]
Balance at Dec. 31, 2015 $ 87 [1] [1]   $ 132 $ 3,089 $ (3,372) $ (64)
Balance, shares at Dec. 31, 2015 8,708,132 [1] [1]   13,182,660        
Conversion of convertible notes and exercise of warrants issued upon conversion $ 48 [1] [1]   1,803 1,851
Conversion of convertible notes and exercise of warrants issued upon conversion, shares 4,746,237 [1] [1]          
Effect of reverse recapitalization $ (135) [1] [1]   $ 153 454 472
Effect of reverse recapitalization, shares (13,454,369) [1] [1]   15,301,675        
Common stock classified as temporary equity [1] [1]   (500) (500) 500
Beneficial Conversion Feature recorded on convertible debt acquired in reverse recapitalization [1] [1]   2,029 2,029
Transaction costs incurred in reverse recapitalization [1] [1]   $ 78 6,817 6,895
Transaction costs incurred in reverse recapitalization, shares [1] [1]   7,802,639        
Cancellation of ordinary shares and issuance of preferred shares [1] [1],[2]   $ (97) 97
Cancellation of ordinary shares and issuance of preferred shares, shares [1] 9,736 [1]   (9,736,000)        
Share based compensation [1] [1]   676 676
Net loss for the period   (9,663) (9,663)
Balance at Dec. 31, 2016 [2]   $ 266 14,465 (13,035) 1,696 500
Balance, shares at Dec. 31, 2016 9,736   26,550,974 [3]        
Share based compensation     $ 1 175 176
Share based compensation, shares     50,000        
Issuance of common stock     $ 45 12,657 12,702
Issuance of common stock, shares     4,450,000        
Cashless exercise of warrants     [2] [2]
Cashless exercise of warrants, shares     359        
Extinguishment of convertible notes and issuance of preferred A shares     [2] 2,676 2,676
Extinguishment of convertible notes and issuance of preferred A shares, shares     3,255        
Conversion of preferred A shares to common stock     [2] $ 58 (58)
Conversion of preferred A shares to common stock, shares     (5,954) 5,954,000        
Net loss for the period     (6,002) (6,002)
Balance at Sep. 30, 2017     [2] $ 370 $ 29,915 $ (19,037) $ 11,248 $ 500
Balance, shares at Sep. 30, 2017     7,037 37,005,333 [3]        
[1] Share data for periods prior to the reverse recapitalization represents the legal equity structure of Microbot Medical Ltd. with the number of shares adjusted to retroactively reflect the one-to-nine Reverse Stock Split effected on November 28, 2016 as well as the reverse recapitalization consummated on November 28, 2016.
[2] Less than 1
[3] Includes 10,702,838 common stock classified as temporary equity.